Add BrightSurf on Google Email

WashU Medicine


Discarded data may be gateway to new brain insights

Researchers found significant patterns in discarded brain wave data, revealing connections between low-frequency and high-frequency brain waves. These connections suggest important aspects of brain architecture and function, potentially shedding light on the brain's organizational structure.

SourceWashU Medicine·JournalNeuron·DateMay 12, 2010

Tweet: Scientists decode songbird's genome

An international team of scientists has decoded the genome of a songbird, the Australian zebra finch, to understand the genetic basis of vocal learning. The analysis suggests that hundreds of genes are activated by singing or hearing songs, including non-coding RNAs that control gene expression.

SourceWashU Medicine·JournalNature·DateMar 31, 2010

'Stepping up' asthma treatment in children leads to improvement

A new study found that increasing dosage or adding asthma drugs to low-dose inhaled corticosteroids improves asthma control in 98% of children. LABA shows the highest response rate, but individual patients require personalized treatment due to factors like Asthma Control Test score, eczema, and ethnicity.

SourceWashU Medicine·JournalNew England Journal of Medicine·DateMar 2, 2010

New subtype of breast cancer responds to targeted drug

Researchers have identified a new biomarker that defines a subtype of aggressive breast cancer and offers potential for targeted therapy. The biomarker, associated with poorer outcomes, can be inhibited by a protein called Mesd, which has shown promise in slowing tumor growth and reducing side effects.

SourceWashU Medicine·JournalProceedings of the National Academy of Sciences·DateMar 1, 2010

Antibiotic found to protect hearing in mice

Researchers discovered that a commonly used antibiotic, kanamycin, protects mouse ears from noise-induced hearing loss when given in low doses. The finding has significant implications for the development of new treatments and could benefit groups such as premature babies, soldiers, and airline workers.

SourceWashU Medicine·JournalJournal of the Association for Research in Otolaryngology·DateJan 27, 2010

Pancreatic tumors are marked for immunotherapy

A study at Washington University School of Medicine identified mesothelin as a marker for pancreatic tumors, suggesting its potential use in immune therapy against the disease. Mesothelin levels in the blood were found to be significantly higher in patients with pancreatic adenocarcinoma compared to healthy individuals.

SourceWashU Medicine·JournalClinical Cancer Research·DateNov 30, 2009

Surgery not linked to memory problems in older patients

Researchers at Washington University School of Medicine studied 575 patients who underwent surgery and found no evidence of long-term cognitive decline. The study suggests that if older adults physically recover from surgery, they will return to their previous level of cognitive ability within six months or a year.

SourceWashU Medicine·JournalAnesthesiology·DateNov 19, 2009

Amaizing: Corn genome decoded

The completed corn genome, published in Science, contains 32,000 genes and will aid in breeding high-yield crops. The sequence, a significant achievement after years of research, offers insights into plant genetics and opens new avenues for crop improvement.

SourceWashU Medicine·JournalScience·DateNov 19, 2009

Scans show learning 'sculpts' the brain's connections

Researchers discovered that learning a new task alters the brain's spontaneous activity patterns, particularly in regions involved in attention and visual processing. This 'anti-correlation' between brain areas improves task performance and facilitates future skill retrieval.

SourceWashU Medicine·JournalProceedings of the National Academy of Sciences·DateOct 8, 2009

Tumors feel the deadly sting of nanobees

Nanobees, nano-sized spheres carrying the toxic melittin from bee venom, successfully delivered and killed tumor cells in mice. By targeting cancerous tissue with precision, nanobees showed promise in treating established and early-stage cancers.

SourceWashU Medicine·JournalJournal of Clinical Investigation·DateAug 10, 2009